Recent advances in the treatment of opiate addiction

被引：18

作者：

Fudala P.J. ^{[1
]}

Woody G.W. ^{[1
]}

机构：

[1] Behavioral Health Service 116, Veterans Affairs Medical Center, Philadelphia, PA 19104, University and Woodland Avenues

来源：

Current Psychiatry Reports | 2004年 / 6卷 / 5期

关键词：

Naloxone; Heroin; Personality Disorder; Buprenorphine; Harm Reduction;

D O I：

10.1007/s11920-004-0020-1

中图分类号：

学科分类号：

摘要：

Although addiction to heroin and other opiates is a major public health issue in the United States and many other counVies, advances in pharmacologic and nonpharmacologic treatment have been made. Some of these advances represent a major shift from traditional treatment philosophies, whereas others are characterized by more subtle, though important, improvements. This review discusses recent advances in opiate-addiction treatment in the context of three main domains: the use of buprenorphine and buprenorphine/naloxone in an office-based paradigm, psychosocial treatment and the addressing of medical and psychiatric comorbidity, and harm reduction strategy. Copyright © 2004 by Current Science Inc.

引用

页码：339 / 346

页数：7

共 57 条

[11]

Sadee W., Rosenbaum J.S., Herz A., Buprenorphine: Differential interaction with opiate receptor subtypes in vivo, J. Pharmacol. Exp. Ther., 223, pp. 157-162, (1982)

[12]

Bloms-Funke P., Gillen C., Schuettler A.J., Wnendt S., Agonistic effects of the opioid buprenorphine on the nociceptin/OFQ receptor, Peptides, 21, pp. 1141-1146, (2000)

[13]

Lee K.O., Akil H., Woods J.H., Traynor J.R., Differential binding properties of oripavines at cloned mu- and delta-opioid receptors, Eur. J. Pharmacol., 378, pp. 323-330, (1999)

[14]

Rothman R.B., Qi N., Heng X., Buprenorphine: A review of the binding literature, Buprenorphine: Combatting Drug Abuse With a Unique Opioid, pp. 19-29, (1995)

[15]

Drugs approved for opiate dependence, FDA Consum, 37, (2003)

[16]

Opioid drugs in maintenance and detoxification treatment of opiate addiction

[17]

addition of buprenorphine and buprenorphine combination to list of approved opioid treatment medications. Interim final rule, Fed. Regist., 68, pp. 27937-27939, (2003)

[18]

(2004)

[19]

Vastig B., In-office opiate treatment "not a panacea." Physicians slow to embrace therapeutic option, J. Am. Med. Assoc., 290, pp. 731-735, (2003)

[20]

(2004)

← 1 2 3 4 5 6 →